Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1

JC Ricarte-Filho, M Ryder, DA Chitale, M Rivera… - Cancer research, 2009 - AACR
Patients with poorly differentiated thyroid cancers (PDTC), anaplastic thyroid cancers (ATC),
and radioactive iodine-refractory (RAIR) differentiated thyroid cancers have a high mortality …

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

RP Tufano, GV Teixeira, J Bishop, KA Carson, M Xing - Medicine, 2012 - journals.lww.com
Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …

BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study

R Elisei, C Ugolini, D Viola, C Lupi… - The Journal of …, 2008 - academic.oup.com
Background: The BRAFV600E mutation is the most frequent genetic alteration in papillary
thyroid carcinoma (PTC). The role of BRAFV600E mutation as a poor prognostic factor has …

Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer

M Xing - Thyroid, 2010 - liebertpub.com
Background: Aberrant activation of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway
plays a fundamental role in thyroid tumorigenesis, particularly in follicular thyroid cancer …

Molecular diagnostics of thyroid tumors

YE Nikiforov - Archives of pathology & laboratory medicine, 2011 - meridian.allenpress.com
Context.—Thyroid cancer is the most common type of endocrine malignancy and its
incidence is steadily increasing. Papillary carcinoma and follicular carcinoma are the most …

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic …

Z Liu, P Hou, M Ji, H Guan, K Studeman… - The Journal of …, 2008 - academic.oup.com
Context: Genetic alterations in receptor tyrosine kinases (RTKs) and phosphatidylinositol 3-
kinase (PI3K)/Akt and MAPK pathways have not been fully defined in anaplastic and …

Molecular diagnostics and predictors in thyroid cancer

MN Nikiforova, YE Nikiforov - Thyroid, 2009 - liebertpub.com
Background: The accuracy of cancer detection in thyroid nodules by fine-needle aspiration
(FNA) cytology and prognostication of thyroid cancer needs further improvement and can …

The BRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single …

R Elisei, D Viola, L Torregrossa… - The Journal of …, 2012 - academic.oup.com
Background: The BRAF V600E mutation, the most frequent genetic alteration in papillary
thyroid carcinoma (PTC), was demonstrated to be a poor prognostic factor. The aim of this …

RAS mutations in thyroid cancer

GM Howell, SP Hodak, L Yip - The oncologist, 2013 - academic.oup.com
RAS Mutations in Thyroid Cancer | The Oncologist | Oxford Academic Skip to Main Content
Advertisement Oxford Academic Journals Books Search Menu Information Account Menu …

Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer

M Ragazzi, A Ciarrocchi, V Sancisi… - International journal …, 2014 - Wiley Online Library
Anaplastic thyroid carcinoma (ATC) is the most aggressive form of thyroid cancer. It shows a
wide spectrum of morphological presentations and the diagnosis could be challenging due …